Details

DSEN Abstract: SGLT2 Inhibitors and the Risk of Major Adverse Cardiovascular Events - CIHR

Metadata and links for an archived snapshot.

Source
Canadian Institutes of Health Research
Date
Feb 19, 2026 · edition #8
Timestamp
2026-02-19T20:05:57.812Z
Language
en
ID
1350762
Status
200
Type
text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots

Archived page preview